Published in J Clin Microbiol on March 01, 2003
Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06
Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol (2005) 1.55
Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol (2004) 1.54
Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis (2007) 1.51
Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology (2009) 1.35
Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. BMC Genomics (2010) 1.34
Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio (2011) 1.21
Throwing the dice for the diagnosis of vaginal complaints? Ann Clin Microbiol Antimicrob (2006) 1.04
The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect (2013) 0.96
The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev (2016) 0.91
Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay. PLoS One (2012) 0.86
Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome (2016) 0.80
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (2000) 5.15
Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol (1983) 4.74
Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol (1989) 4.03
The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis (1999) 3.95
Quantitative bacteriology of the vaginal flora. J Infect Dis (1977) 3.81
Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med (1995) 3.34
The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol (1984) 3.15
Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1992) 2.27
The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol (1992) 2.15
Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol (1987) 2.11
Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol (1996) 2.07
Methods for quantitative vaginal flora studies. Am J Obstet Gynecol (1977) 2.05
Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract (1999) 2.04
Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J Clin Microbiol (1994) 1.83
Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation. Appl Environ Microbiol (1986) 1.67
Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol (1992) 1.61
Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol (1990) 1.52
Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.50
Qualitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.47
Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. Am J Obstet Gynecol (1978) 1.39
A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol (1994) 1.35
Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1998) 1.32
Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol (1990) 1.30
Preterm birth and infection: pathogenic possibilities. Am J Reprod Immunol Microbiol (1988) 1.26
The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis (1995) 1.18
Novel lantibiotics and their pre-peptides. Antonie Van Leeuwenhoek (1996) 1.12
The relationship between bacterial vaginosis and preterm birth. A review. Arch Gynecol Obstet (1997) 1.12
Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection (1997) 1.10
Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol (1995) 1.03
The role of mycoplasmas, ureaplasmas and chlamydiae in the genital tract of women presenting in spontaneous early preterm labour. J Med Microbiol (1987) 1.01
Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet Gynecol (1991) 0.99
Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. The Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Sex Transm Dis (1992) 0.98
Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstet Gynecol (1995) 0.94
Infection and labor. VI. Prevalence, microbiology, and clinical significance of intraamniotic infection in twin gestations with preterm labor. Am J Obstet Gynecol (1990) 0.90
Normal vaginal microflora during use of various forms of catamenial protection. Rev Infect Dis (1989) 0.88
Mixed-effect models for predicting microbial interactions in the vaginal ecosystem. J Clin Microbiol (1994) 0.86
Human neutrophil oxidative response and phagocytic killing of clinical and laboratory strains of Enterococcus faecalis. Diagn Microbiol Infect Dis (1993) 0.84
Preterm labor and congenital candidiasis. A case report. J Reprod Med (1994) 0.84
Vaginal infections, cervical ripening and preterm delivery. Eur J Obstet Gynecol Reprod Biol (1991) 0.79
Vaginitis including bacterial vaginosis. Curr Opin Obstet Gynecol (1994) 0.78
Preterm labor, preterm delivery, intrauterine infection, and preterm rupture of membranes. Curr Opin Obstet Gynecol (1990) 0.78
Significance of positive cervical cultures for Chlamydia trachomatis in patients with preterm premature rupture of membranes. Am J Perinatol (1992) 0.77
Prematurity prevention: who is at risk? Clin Perinatol (1992) 0.77
Bacterial vaginosis: its importance in obstetrics. Hosp Med (1998) 0.77
Low birthweight and post partum endometritis-myometritis. Acta Obstet Gynecol Scand (1995) 0.77
Erythromycin treatment for subclinical Ureaplasma urealyticum infection in preterm labor. Fetal Diagn Ther (1997) 0.77
Screening for Ureaplasma urealyticum infections in the neonate and the association with prematurity. Eur J Obstet Gynecol Reprod Biol (1986) 0.76
Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe (2010) 4.54
Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr (2008) 2.38
Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis (2010) 2.35
Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol (2008) 2.28
Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A (2010) 2.10
The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol (2004) 1.82
Gender differences in research grant applications and funding outcomes for medical school faculty. J Womens Health (Larchmt) (2008) 1.81
Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestation. Pediatrics (2013) 1.81
Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol (2008) 1.76
Randomized comparison of chromic versus fast-absorbing polyglactin 910 for postpartum perineal repair. Obstet Gynecol (2004) 1.65
A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstet Gynecol (2004) 1.60
Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr (2005) 1.57
Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol (2005) 1.52
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol (2005) 1.49
Predictors of repeat pregnancy among HIV-1-infected women. J Acquir Immune Defic Syndr (2007) 1.48
Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus. J Infect Dis (2013) 1.43
Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio (2011) 1.42
Tracheal tube obstruction in mechanically ventilated patients assessed by high-resolution computed tomography. Anesthesiology (2014) 1.41
Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics (2011) 1.40
Assessment of the rate of uterine rupture at the first prenatal visit: a preliminary evaluation. J Matern Fetal Neonatal Med (2008) 1.39
"Real World" compliance with strategies to prevent early-onset group B streptococcal disease. J Perinatol (2003) 1.38
Prophylactic acetaminophen does not prevent epidural fever in nulliparous women: a double-blind placebo-controlled trial. J Perinatol (2004) 1.38
Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure. AIDS (2009) 1.36
Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother (2006) 1.32
The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med (2002) 1.23
Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio (2011) 1.21
Protection from oxidative damage using Bidens pilosa extracts in normal human erythrocytes. Food Chem Toxicol (2006) 1.18
Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol (2004) 1.09
Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling. Obstet Gynecol (2015) 1.07
Mode of delivery and cord blood cytokines: a birth cohort study. Clin Mol Allergy (2006) 1.07
Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression. Respir Res (2006) 1.05
What factors are associated with parents' desire to know the sex of their unborn child? Birth (2004) 1.05
Herpes simplex virus hepatitis causing acute liver dysfunction and thrombocytopenia in pregnancy. Obstet Gynecol (2005) 1.05
The nature and management of labor pain: executive summary. Am J Obstet Gynecol (2002) 1.04
Elevated maternal and fetal serum interleukin-6 levels are associated with epidural fever. Am J Obstet Gynecol (2002) 1.02
Persistent fetal occiput posterior position: obstetric outcomes. Obstet Gynecol (2003) 1.00
Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. AIDS (2010) 1.00
Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy (2008) 0.97
The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect (2013) 0.96
Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med (2002) 0.95
Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women. BMC Infect Dis (2010) 0.93
Acute histologic chorioamnionitis at term: nearly always noninfectious. PLoS One (2012) 0.93
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy. AIDS (2010) 0.92
Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy. Obstet Gynecol (2004) 0.91
Protease inhibitor use during pregnancy: is there an obstetrical risk? J Infect Dis (2006) 0.90
Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol (2004) 0.88
Intrapartum temperature elevation, epidural use, and adverse outcome in term infants. Pediatrics (2012) 0.87
In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico. Int J Dermatol (2010) 0.87
Narrowing of sex differences in infant mortality in Massachusetts. J Perinatol (2004) 0.87
Patterns of pregnancy-related hypertension in black and white women. Hypertens Pregnancy (2005) 0.84
Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection. Antimicrob Agents Chemother (2006) 0.84
The association of maternal age and symptomatic uterine rupture during a trial of labor after prior cesarean delivery. Obstet Gynecol (2002) 0.83
High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998-2004. AIDS (2007) 0.83
Expectant management in spontaneous preterm premature rupture of membranes between 14 and 24 weeks' gestation. J Perinatol (2004) 0.82
The role of intrapartum fever in identifying asymptomatic term neonates with early-onset neonatal sepsis. J Perinatol (2002) 0.81
Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing age. Antimicrob Agents Chemother (2011) 0.81
TNFA-308G>A polymorphism influences the TNF-alpha response to altered vaginal flora. Eur J Obstet Gynecol Reprod Biol (2006) 0.80
Effects of feminine hygiene products on the vaginal mucosal biome. Microb Ecol Health Dis (2013) 0.80
Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study. AIDS (2006) 0.79
No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol (2005) 0.79
Vaginal nitric oxide in pregnant women with bacterial vaginosis. Am J Reprod Immunol (2006) 0.78
Humic acid induced genotoxicity in human peripheral blood lymphocytes using comet and sister chromatid exchange assay. J Hazard Mater (2007) 0.78
Post-cesarean delivery fever and uterine rupture in a subsequent trial of labor. Obstet Gynecol (2003) 0.78
Neonatal outcome after trial of labor compared with elective repeat cesarean section. Birth (2003) 0.77
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol (2006) 0.77
Association between vaginal 70-kd heat shock protein, interleukin-1 receptor antagonist, and microbial flora in mid trimester pregnant women. Am J Obstet Gynecol (2005) 0.77
Maternal temperature elevation and occiput posterior position at birth among low-risk women receiving epidural analgesia. J Midwifery Womens Health (2011) 0.77
Maternal epidural analgesia and rates of maternal antibiotic treatment in a low-risk nulliparous population. J Perinatol (2003) 0.77
Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025. J Acquir Immune Defic Syndr (2016) 0.76
First birth cesarean and risk of antepartum fetal death in a subsequent pregnancy. J Midwifery Womens Health (2012) 0.76
No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Am J Obstet Gynecol (2008) 0.75
Postpartum Laboratory Follow-up in Women With Hepatitis B in Massachusetts From 2007 to 2012. J Clin Gastroenterol (2016) 0.75
Impact of single- or double-layer closure on uterine rupture. Am J Obstet Gynecol (2003) 0.75
Pregnancy Options Counseling and Abortion Referrals Among US Primary Care Physicians: Results From a National Survey. Fam Med (2017) 0.75
Peripartum bacteremia in the era of group B streptococcus prophylaxis. Obstet Gynecol (2013) 0.75
Association of Intended Route of Delivery and Maternal Morbidity in Twin Pregnancy. Obstet Gynecol (2017) 0.75
The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer. Int J Radiat Oncol Biol Phys (2006) 0.75